![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Podophyllotoxin: Recent Advances in the Development of Hybridization Strategies to Enhance Its Antitumoral Profile
Carolina Miranda‐Vera, Ángela‐Patricia Hernández, Pilar Garcı́a Garcı́a, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2728-2728
Open Access | Times Cited: 7
Carolina Miranda‐Vera, Ángela‐Patricia Hernández, Pilar Garcı́a Garcı́a, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2728-2728
Open Access | Times Cited: 7
Showing 7 citing articles:
Bioconjugation of Podophyllotoxin and Nanosystems: Approaches for Boosting Its Biopharmaceutical and Antitumoral Profile
Carolina Miranda‐Vera, Ángela‐Patricia Hernández, Pilar Garcı́a Garcı́a, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 169-169
Open Access
Carolina Miranda‐Vera, Ángela‐Patricia Hernández, Pilar Garcı́a Garcı́a, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 169-169
Open Access
Historical Perspective and Current Trends in Anticancer Drug Development
Katarzyna Gach, Joanna Drogosz-Stachowicz, Anna Janecka, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1878-1878
Open Access | Times Cited: 3
Katarzyna Gach, Joanna Drogosz-Stachowicz, Anna Janecka, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1878-1878
Open Access | Times Cited: 3
A Natural Compound-Empowered Podophyllotoxin Prodrug Nanoassembly Magnifies Efficacy-Toxicity Benefits in Cancer Chemotherapy
Ziqi Lin, Yuequan Wang, Wenwen Li, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 4, pp. 100892-100892
Open Access | Times Cited: 2
Ziqi Lin, Yuequan Wang, Wenwen Li, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 4, pp. 100892-100892
Open Access | Times Cited: 2
Cellular Distribution and Ultrastructural Changes in HaCaT Cells, Induced by Podophyllotoxin and Its Novel Fluorescent Derivative, Supported by the Molecular Docking Studies
Piotr Strus, Karol Sadowski, Julia Kostro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5948-5948
Open Access | Times Cited: 2
Piotr Strus, Karol Sadowski, Julia Kostro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5948-5948
Open Access | Times Cited: 2
Cytotoxic Cyclolignans Obtained by the Enlargement of the Cyclolignan Skeleton of Podophyllic Aldehyde, a Selective Podophyllotoxin-Derived Cyclolignan
Pablo A. García, Ángela‐Patricia Hernández, Ma Antonia Gómez-Zurita, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1442-1442
Open Access
Pablo A. García, Ángela‐Patricia Hernández, Ma Antonia Gómez-Zurita, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1442-1442
Open Access
Self-assembled stimuli-responsive adamantanamine-podophyllotoxin conjugate/β-cyclodextrins inclusion complex for enhanced solubility and anticancer activity
Lei Chen, Yang Song, Lian Deng, et al.
Journal of Molecular Structure (2024) Vol. 1324, pp. 140752-140752
Closed Access
Lei Chen, Yang Song, Lian Deng, et al.
Journal of Molecular Structure (2024) Vol. 1324, pp. 140752-140752
Closed Access
Beyond Essential Oils: Diterpenes, Lignans, and Biflavonoids from Juniperus communis L. as a Source of Multi-Target Lead Compounds
Alina Arabela Jojić, Sergio Liga, Diana Uțu, et al.
Plants (2024) Vol. 13, Iss. 22, pp. 3233-3233
Open Access
Alina Arabela Jojić, Sergio Liga, Diana Uțu, et al.
Plants (2024) Vol. 13, Iss. 22, pp. 3233-3233
Open Access
4′-Demethylpodophyllotoxin functions as a mechanism-driven therapy by targeting the PI3K-AKT pathway in Colorectal cancer
Jun Liu, Dandong Luo, Xiaochuan Chen, et al.
Translational Oncology (2024) Vol. 51, pp. 102199-102199
Closed Access
Jun Liu, Dandong Luo, Xiaochuan Chen, et al.
Translational Oncology (2024) Vol. 51, pp. 102199-102199
Closed Access